Alexandria Ocasio-Cortez

Democratic Rep. Alexandria Ocasio-Cortez on Thursday confronted the CEO of the drug company Gilead over the high cost of an HIV-prevention drug.
Ocasio-Cortez asked why the drug Truvada costs nearly $2,000 per month in the US compared to $8 in Australia.
Gilead CEO Daniel O’Day said that the current monthly list price ($1,780) is a product of the drug’s “patent protection” in the US, while a generic version of the drug is sold in other countries.

The drug was developed by the US government with taxpayer funds, which Ocasio-Cortez zeroed in on as she rebuked the high cost of Truvada.
Visit BusinessInsider.com for more stories.

Democratic Rep. Alexandria Ocasio-Cortez of New York on Thursday confronted a drug company CEO about the high cost of an HIV-prevention drug.

Speaking to Gilead CEO Daniel O’Day, Ocasio-Cortez asked why the drug Truvada for PrEP (pre-exposure prophylaxis), which can help reduce the risk of contracting HIV via sex, cost nearly $2,000 per month in the US, versus $8 in Australia.

O’Day said that the current monthly list price ($1,780) is a product of the drug’s “patent protection” in the US, while a generic version of the drug is sold in other countries.

The Gilead CEO did not offer …read more


Source:: Businessinsider – Politics

      

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *